Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05552664 · ClinicalTrials.gov registry record · NA
The Genetic Information and Family Testing (GIFT) Study
A NA study of Cancer, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 3,002
- Enrollment target
- 4
- Study locations
NCT05552664 is a NA study of Cancer that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 3,002 participants, below the 3,486-participant average among 615 other Cancer trials with a reported enrollment target (14% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT05552664, a NA study of Cancer, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,002 participants
- Enrollment target
- 4
- Study locations
Study Summary
The Genetic Information and Family Testing (GIFT) Study is designed to support the capacity, opportunity, and motivation of cancer patients to engage their relatives about inherited cancer susceptibility and provide support and services to those relatives to initiate GRE (including genetic testing) and prepare them to subsequently engage their clinicians in informed decision-making about cancer prevention and early detection.
Conditions Studied
Interventions
- GENETIC GIFT
Study Locations (4)
California
- University of Southern California - Los Angeles
- Stanford University - Stanford
Georgia
- Emory University - Atlanta
Michigan
- University of Michigan Rogel Cancer Center - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,002 participants |
| Start Date | 2022-10-24 |
| Est. Completion | 2025-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05552664
The ClinicalTrials.gov registry entry for NCT05552664 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,002 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,486-participant average among 615 other Cancer trials with a reported enrollment target (14% lower). The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which GIFT is the first listed.
NCT05552664 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, Georgia, Michigan.
Frequently Asked Questions
What is clinical trial NCT05552664 about?
NCT05552664 is a clinical study titled "The Genetic Information and Family Testing (GIFT) Study". The Genetic Information and Family Testing (GIFT) Study is designed to support the capacity, opportunity, and motivation of cancer patients to engage their relatives about inherited cancer susceptibility and provide support and services to those relatives to initiate GRE (including genetic testing) ...
What is the current status of trial NCT05552664?
This trial is currently completed. It is a NA study. The enrollment target is 3,002 participants. The study started on 2022-10-24. Estimated completion is 2025-08-10.
What conditions does trial NCT05552664 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT05552664?
The interventions under investigation include: GIFT (GENETIC).
Who is sponsoring clinical trial NCT05552664?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05552664 being conducted?
This trial has 4 study locations across California, Georgia, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.